| Literature DB >> 36237655 |
Katelyn M Waring, Edward R Smith, Gary P Austin, Thomas G Bowman.
Abstract
Background: Cervical (neck) strengthening has been proposed as an important factor in concussion prevention. The purpose of the study was to determine if a six-week cervical strengthening program affected neurocognition and purposeful soccer heading biomechanics. The hypothesis was that the neck strengthening program would improve strength, maintain neurocognition, and alter purposeful soccer heading biomechanics. Study Design: Randomized controlled trial.Entities:
Keywords: CNS vital signs; cervical strength; concussion prevention
Year: 2022 PMID: 36237655 PMCID: PMC9528716 DOI: 10.26603/001c.38327
Source DB: PubMed Journal: Int J Sports Phys Ther ISSN: 2159-2896
Demographic information across experimental and control groups.
| Experimental | Control | Comparison | |
| Age | 20.57±1.13 | 19.44±1.42 | p=0.04, Cohen’s d=1.03 |
| Height | 177.43±7.79 | 169.00±8.56 | p=0.13, Cohen’s d=0.79 |
| Mass | 75.94±11.44 | 66.23±9.93 | p=0.09, Cohen’s d=0.92 |
| Neck Girth | 37.50±2.78 | 34.06±2.79 | p=0.03, Cohen’s d=1.14 |
| Neck Length | 24.71±0.76 | 23.11±1.97 | p=0.14, Cohen’s d=0.77 |
Figure 1.Positions for neck strength measurements: anterior neck flexors (A), bilateral anterolateral neck flexors (B), bilateral cervical rotators (C), bilateral posterolateral neck extensor (D)
Strength training prescription during the six-week protocol
| Week | Sets | Repetitions |
| Week 1 | 1 | 10 |
| Week 2 | 1 | 12 |
| Week 3 | 1 | 15 |
| Week 4 | 2 | 10 |
| Week 5 | 2 | 12 |
| Week 6 | 2 | 15 |
Figure 2.Example of cervical extension strengthening exercise using the Shingo Imara (Shingo Imara, Ann Arbor, Michigan)
Mean and standard deviations for strength testing dependent variables
| Strengthening Group | Control Group | Interaction | |||
| Pre | Post | Pre | Post | ||
| Anterior Strength | 20.72±5.54 | 28.29±7.25 | 16.41±4.50 | 20.11±4.96 | p=0.04, ηp2=0.22 |
| Right Anterolateral Strength | 19.91±5.49 | 26.68±5.78 | 16.45±3.80 | 18.97±3.95 | p=0.04, ηp2=0.22 |
| Left Anterolateral Strength | 19.58±5.45 | 26.43±7.04 | 16.91±4.69 | 19.18±4.11 | p=0.02, ηp2=0.28 |
| Right Rotation Strength | 19.32±4.98 | 21.37±5.19 | 17.20±3.70 | 16.52±3.08 | p=0.16, ηp2=0.11 |
| Left Rotation Strength | 19.61±4.86 | 21.20±3.84 | 18.03±4.22 | 17.09±3.28 | p=0.09, ηp2=0.16 |
| Right Posterolateral Strength | 27.04±7.40 | 35.15±7.21 | 25.94±5.03 | 29.96±5.50 | p=0.10, ηp2=0.15 |
| Left Posterolateral Strength | 27.88±6.64 | 36.37±9.78 | 27.09±5.71 | 30.30±6.42 | p=0.10, ηp2=0.14 |
Mean and standard deviations for heading biomechanics dependent variables
| Strengthening Group | Control Group | Interaction | |||
| Pre | Post | Pre | Post | ||
| PLA at 11.18 m/s | 22.70±2.11 | 20.01±1.59 | 22.10±2.72 | 25.21±5.44 | p=0.43, ηp2=0.06 |
| PRA at 11.18 m/s | 4456.20±916.54 | 3547.10±835.10 | 5027.84±793.66 | 4046.62±508.83 | p=0.96, ηp2<0.01 |
| Duration at 11.18 m/s | 10.35±0.99 | 8.78±1.28 | 11.50±3.22 | 15.13±5.95 | p=0.53, ηp2=0.04 |
| GSI at 11.18 m/s | 24.78±5.08 | 16.88±3.23 | 26.30±8.59 | 43.72±23.59 | p=0.33, ηp2=0.09 |
| PLA at 17.88 m/s | 30.84±4.45 | 22.83±3.29 | 25.24±1.45 | 20.89±3.56 | p=0.34, ηp2=0.08 |
| PRA at 17.88 m/s | 4279.75±1126.39 | 3383.56±946.99 | 4838.79±219.14 | 3843.23±614.17 | p=0.97, ηp2<0.001 |
| Duration at 17.88 m/s | 11.34±1.38 | 8.91±2.05 | 12.02±2.56 | 8.59±1.51 | p=0.79, ηp2=0.01 |
| GSI at 17.88 m/s | 41.98±12.13 | 22.30±7.04 | 31.70±4.11 | 19.51±5.39 | p=0.48, ηp2=0.05 |
PLA=peak linear acceleration, PRA=peak rotational acceleration, GSI=Gadd Severity Index
Mean values and standard deviations for cognitive dependent variables
| Strengthening Group | Control Group | Interaction | |||
| Pre | Post | Pre | Post | ||
| Visual Memory | 46.67±4.77 | 47.67±4.90 | 46.89±4.73 | 42.78±4.21 | p=0.04, ηp2=0.23 |
| Verbal Memory | 51.00±4.69 | 49.00±5.41 | 51.56±4.64 | 49.11±5.65 | p=0.91, ηp2<0.001 |
| Executive Function | 53.78±8.06 | 48.44±10.92 | 51.67±8.76 | 49.00±9.07 | p=0.41, ηp2=0.04 |
| Reaction Time | 598.67±48.61 | 638.56±45.20 | 630.00±73.40 | 638.00±109.01 | p=0.32, ηp2=0.06 |
| Symptom Severity Score | 9.22±12.03 | 4.56±6.23 | 7.44±7.32 | 11.67±14.82 | p=0.14, ηp2=0.12 |